Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Novel Thoracic Wall Blocks With Dexmetomidine on Inflammatory Markers Following Breast Cancer Surgery

NCT04860115 is registered in ClinicalTrials.gov with St. Elizabeth Cancer Institute, Slovakia as lead sponsor.

NCT NCT04860115
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04860115 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Novel Thoracic Wall Blocks With Dexmetomidine on Inflammatory Markers Following Breast Cancer Surgery
Lead sponsor
St. Elizabeth Cancer Institute, Slovakia
Phase
Not applicable
Overall status
Unknown status
Start date
November 1, 2021
Completion date
December 1, 2023
Enrollment
120 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory markers